Handelsavisen
prelaunch
Companies Healthcare 9647.SE
96
9647.SE Tadawul Medical Equipment, Supplies & Distribution

9647.Se

$5,07
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
19,0 %
Net margin
7,0 %
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
19,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 9647.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 9647.SE. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a strong capital structure with no debt, as evidenced by a debt-to-equity ratio of 0.0. This indicates a conservative approach to financing, with total equity of 31,523,540.0. The company's liquidity position is not directly assessable due to the absence of balance-sheet inputs and no going-concern language in the source documents.

    Profitability is robust, with a return on equity of 0.1897. This performance is in line with the industry's preferred metrics, which emphasize efficient use of equity capital to generate returns. The company's net income of 5,981,470.0 reflects its ability to convert revenue into profit, with a revenue of 85,197,760.0.

    The company's revenue is not segmented by geographic regions or business lines in the available data, making it difficult to assess the concentration of revenue across different markets or product lines. However, the absence of detailed segment data suggests a potentially diversified revenue base or a lack of public disclosure on this aspect.

    The company's growth trajectory is not explicitly outlined in the available data, but the current revenue of 85,197,760.0 provides a baseline for future performance. The outlook for the current fiscal year and the next fiscal year is not specified, but the company's profitability and capital structure suggest a stable financial position.

    The risk assessment indicates a low potential for dilution, with no significant dilution risk identified. The company's conservative capital structure, with no debt, and the absence of dilution risk factors suggest a stable equity position. However, the liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.

    Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The absence of detailed information on recent events suggests a need for further investigation into the company's strategic direction and operational performance.

    Key takeaways
    • The company has a strong return on equity of 0.1897, indicating efficient use of equity capital.
    • The company maintains a conservative capital structure with no debt, as shown by a debt-to-equity ratio of 0.0.
    • The company's liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.
    • The company's revenue is not segmented by geographic regions or business lines, making it difficult to assess the concentration of revenue across different markets or product lines.
    • The company has a low potential for dilution, with no significant dilution risk identified.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $5,07
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    19.0%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    Net Margin7,0 %Above median
    ROE19,0 %Best in class
    D/E0,00Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Return On Equity
      net_income / total_equity
    Source documents
    • 9647.SE Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    9647.SECanonical
    Tadawul · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage